Migraine Treatment Recommendations
NSAIDs are the first-line treatment for mild to moderate migraines, while triptans are recommended for moderate to severe migraines or when NSAIDs fail. 1
Acute Treatment Algorithm
Mild to Moderate Migraines
- First-line: NSAIDs
Moderate to Severe Migraines
- First-line: Triptans (serotonin 5-HT1B/D agonists)
- Sumatriptan 50mg orally (recommended starting dose)
- Sumatriptan 100mg may provide greater efficacy but with more side effects 1, 2
- Sumatriptan 6mg subcutaneously for severe attacks or significant nausea/vomiting 1
- Other options: rizatriptan, naratriptan, zolmitriptan 1
- Maximum daily dose of sumatriptan: 200mg in a 24-hour period 2
- If migraine hasn't resolved after 2 hours, a second dose may be administered 2
When Triptans Fail or are Contraindicated
- Alternative options:
Special Considerations
Patients with Nausea/Vomiting
- Use non-oral routes of administration:
- Sumatriptan subcutaneous injection
- Intranasal DHE
- Add antiemetic medication to treat nausea 1
Patients with Hepatic Impairment
- For mild to moderate hepatic impairment, maximum single dose of sumatriptan should not exceed 50mg 2
Timing of Medication
- Taking medication early, during the mild pain phase, provides significantly better outcomes than treating established attacks with moderate or severe pain 3
Preventive Treatment
When to Consider Prevention
- ≥2 migraine attacks per month with significant disability
- Acute treatments used more than twice weekly 1
Preventive Options
- First-line: Beta blockers (e.g., propranolol 80-240 mg/day) - high level of evidence 1
- Other options:
Avoiding Medication Overuse Headache
- Limit NSAIDs to no more than 15 days per month
- Limit triptans to no more than 9 days per month
- Limit OTC medications to no more than 14 days per month
- Limit Ubrelvy to no more than 8 days per month 1
Non-Pharmacological Approaches
- Regular aerobic exercise or strength training
- Maintain regular sleep schedule
- Adequate hydration
- Identify and avoid triggers
- Relaxation techniques or mindfulness
- Neuromodulatory devices, biobehavioral therapy, and acupuncture as adjuncts or standalone treatments when medications are contraindicated 1
Efficacy and Monitoring
- Assess treatment efficacy after 2-3 months for oral preventives and 3-6 months for CGRP monoclonal antibodies
- Evaluate patients for high-risk factors including anxiety, depression, and medication overuse 1
Important Cautions
- Triptans are contraindicated in patients with uncontrolled hypertension, basilar or hemiplegic migraine, and cardiovascular disease 1
- Adverse events with sumatriptan are generally transient and mild, with a clear dose-response relationship (25mg to 100mg) 3
- Subcutaneous administration provides more rapid pain relief than other routes but has higher rates of adverse events 4